We build cross-functional teams made up of research scientists, hardware and software engineers, physicians and commercial experts. Our multidisciplinary teams have access to advanced research tools, large scale computing power and unique technical expertise.
Andy Conrad, Ph.D.Chief Executive Officer
Formerly the chief scientific officer of LabCorp, Andy is a cell biologist with a doctorate from UCLA. He has always been passionate about early detection and prevention of disease. Andy co-founded the National Genetics Institute, which developed the first cost-effective test to screen for HIV in the blood supply.
Ashraf Hanna, M.D., Ph.D.Chief Operating Officer
Ashraf Hanna is the COO of Verily. Previously he was the CEO of ORIC Pharmaceuticals, a company focused on the development of treatments for cancer resistance. Before that Ashraf spent nearly 11 years as a Vice President at Genentech leading the Commercial and Medical Affairs Finance functions, as well as Alliance Management and Portfolio Planning group, which is responsible for developing metrics and process for guiding R&D investments. Ashraf was also the CFO for the Genentech foundation, and previously at McKinsey and Company. He is a graduate of University of Chicago, has a Ph.D. in Physics from Harvard University and an M.D. from the University of Massachusetts.
Sheela KrothapalliHead of People Operations
Sheela leads Verily's People Operations team providing strategic HR partnership to the business, and overseeing the recruiting function. The team ensures that Verily has the talent, operational support, and people programs to grow and execute. Prior to joining Verily as its first dedicated People Ops hire, Sheela spent over seven years working at Google. Sheela has a B.S. from Cornell University in Industrial and Labor Relations, and also studied International Relations and Law.
Jessica Mega, M.D., M.P.H.Chief Medical Officer
Jessica L. Mega, MD, MPH, is the Chief Medical Officer at Verily Life Sciences. As CMO, Dr. Mega's focus is on translating technological innovations and scientific insights into partnerships and programs that improve patient outcomes. She oversees all of Verily's clinical and science efforts, including the Baseline Study. As a faculty member at Harvard Medical School, a senior investigator with the TIMI Study Group, and a cardiologist at Brigham and Women's Hospital, she led large, international, randomized trials evaluating novel cardiovascular therapies. She also directed the TIMI Study Group’s Genetics Program. Her findings have been published in the New England Journal of Medicine, Lancet, JAMA, and elsewhere. Dr. Mega sits on the advisory group for the California Governor on Precision Medicine. She is a graduate of Stanford University, Yale University School of Medicine and Harvard School of Public Health.
Brian Otis, Ph.D.Chief Technical Officer
Brian’s team focuses on end-to-end innovation ranging from integrated circuits to biocompatible materials to sensors. He joined Verily from the University of Washington Department of Engineering as founder of the smart contact lens project. He leads the company’s efforts across all hardware and device projects, including wearables, implanted devices and technology including Liftware. Previously, Brian held positions at the University of Washington Kelly Tremblay Brain and Behavior Laboratory, the UC-Berkeley Ralph Freeman Neuroscience Lab, Intel Corporation and Agilent Laboratories. He received his M.S. and Ph.D. in Electrical engineering, in the field of low power integrated circuits for wireless sensors, from the University of California, Berkeley.
Tom StanisHead of Software
Tom leads all of Verily's software projects, including the development of machine learning algorithms for applications ranging from robotic-assisted surgery to diabetes management. Prior to joining Verily, he spent nine years working on core Google products and five years at Electronic Arts. Throughout his career, Tom's focus has been on improving the user experience, performance and scalability of systems through cross-functional collaboration. He received his B.S. from UW Madison.
Linus UpsonHead of Engineering
Linus Upson joined Google in 2005 and is a vice president at Verily. He leads Verily’s Debug Project and oversees engineering and user experience. Earlier he was responsible for overseeing Google’s browser products including Chrome and Chrome OS. Prior to Google, Linus was an engineer at NeXT and Netscape and co-founded two companies, AvantGo and Qurb. Linus is on an extended leave from his undergraduate studies in mathematics at Princeton University.
Claudia WalshGeneral Counsel
Claudia leads the legal department and oversees general and administrative functions at Verily. She’s a deal lawyer that joined Google in 2007, where she supported the strategic partnerships organization across a variety of product areas. She took over leadership of the X legal team in 2014 and shifted fully to Verily in 2015. Prior to Google she practiced corporate law at Morrison & Foerster in Palo Alto. She received her B.A. from Stanford University and J.D. from University of California, Hastings College of the Law.
Carolyn WangHead of Communications
Before leading communications and marketing at Verily, Carolyn was President of Brewlife, a W2O Group agency. There she focused on strategic branding and communications consulting for emerging brands, predominantly in life sciences and healthcare. Prior to Brewlife, Carolyn helped to build the digital health group within WCG, another W2O Group agency, where she led the healthcare practice. Carolyn received her B.S. in biology from Elon University.
Duncan WelsteadChief Financial Officer
Duncan joined Verily in 2014 and leads the finance team. Previously, Duncan worked in finance at YouTube with a focus on content licensing & partnerships. Prior to Alphabet, Duncan worked in private equity investing with Halyard Capital, a mid-market growth equity firm, and in investment banking at BMO Capital. Duncan completed his MBA at Columbia Business School and graduated with a BSc in Mechanical Engineering from Brown University.